Stability of miR-126 in urine and its potential as a biomarker for renal endothelial injury with diabetic nephropathy

International Journal of Endocrinology

Volumn 2014, Issue , 2014, Pages

  Liu, Yang ^a   Gao, Guangqiang ^a   Yang, Chun ^a   Zhou, Kun ^a   Shen, Baozhong ^a,b   Liang, Hongyan ^a,b   Jiang, Xiaofeng ^a,b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Heilongjiang Province Key Laboratory of Molecular Imaging   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; HEMOGLOBIN A1C; MICRORNA 126;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; ENDOTHELIUM INJURY; FEASIBILITY STUDY; FEMALE; FREEZE THAWING; HUMAN; KIDNEY INJURY; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT MONITORING; REAL TIME POLYMERASE CHAIN REACTION; RENAL ENDOTHELIAL INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA STABILITY; ROOM TEMPERATURE; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE; URINALYSIS;

EID: 84900009766     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2014/393109     Document Type: Article

References (39)

1. Ambros V., microRNAs: tiny regulators with great potential. Cell 2001 107 7 823 826 2-s2.0-0035966319 10.1016/S0092-8674(01)00616-X
2. Bartel D. P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004 116 2 281 297 2-s2.0-0347444723 10.1016/S0092-8674(04)00045-5
3. Ambros V., The functions of animal microRNAs. Nature 2004 431 7006 350 355 2-s2.0-4644309196 10.1038/nature02871
4. Bartel D. P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004 116 2 281 297 2-s2.0-0347444723 10.1016/S0092-8674(04)00045-5
5. Sempere L. F., Freemantle S., Pitha-Rowe I., Moss E., Dmitrovsky E., Ambros V., Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biology 2004 5 3, article R13 2-s2.0-1942494040
6. Ning M. S., Kim A. S., Prasad N., Levy S. E., Zhang H., Andl T., Characterization of the merkel cell carcinoma miRNome. Journal of Skin Cancer 2014 2014 9 289548 10.1155/2014/289548
7. Ji X., Takahashi R., Hiura Y., Hirokawa G., Fukushima Y., Iwai N., Plasma miR-208 as a biomarker of myocardial injury. Clinical Chemistry 2009 55 11 1944 1949 2-s2.0-70449709345 10.1373/clinchem.2009.125310
8. Wang G.-K., Zhu J.-Q., Zhang J.-T., Li Q., Li Y., He J., Qin Y.-W., Jing Q., Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. European Heart Journal 2010 31 6 659 666 2-s2.0-77954161288 10.1093/eurheartj/ehq013
9. Wang K., Zhang S., Marzolf B., Troisch P., Brightman A., Hu Z., Hood L. E., Galas D. J., Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proceedings of the National Academy of Sciences of the United States of America 2009 106 11 4402 4407 2-s2.0-63149121152 10.1073/pnas. 0813371106
10. Starkey Lewis P. J., Dear J., Platt V., Simpson K. J., Craig D. G. N., Antoine D. J., French N. S., Dhaun N., Webb D. J., Costello E. M., Neoptolemos J. P., Moggs J., Goldring C. E., Park B. K., Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology 2011 54 5 1767 1776 2-s2.0-80055038826 10.1002/hep.24538
11. Kerr T. A., Korenblat K. M., Davidson N. O., MicroRNAs and liver disease. Translational Research 2011 157 4 241 252 2-s2.0-79952792083 10.1016/j.trsl.2011.01.008
12. Weber J. A., Baxter D. H., Zhang S., Huang D. Y., Huang K. H., Lee M. J., Galas D. J., Wang K., The microRNA spectrum in 12 body fluids. Clinical Chemistry 2010 56 11 1733 1741 2-s2.0-78149484489 10.1373/clinchem.2010.147405
13. Tzimagiorgis G., Michailidou E. Z., Kritis A., Markopoulos A. K., Kouidou S., Recovering circulating extracellular or cell-free RNA from bodily fluids. Cancer Epidemiology 2011 35 6 580 589 2-s2.0-81055138737 10.1016/j.canep.2011. 02.016
14. Cortez M. A., Bueso-Ramos C., Ferdin J., Lopez-Berestein G., Sood A. K., Calin G. A., MicroRNAs in body fluids-the mix of hormones and biomarkers. Nature Reviews Clinical Oncology 2011 8 8 467 477 2-s2.0-79961025970 10.1038/nrclinonc.2011.76
15. Declèves A.-E., Sharma K., New pharmacological treatments for improving renal outcomes in diabetes. Nature Reviews. Nephrology 2010 6 6 371 380 2-s2.0-77956628272 10.1038/nrneph.2010.57
16. Susztak K., Raff A. C., Schiffer M., Böttinger E. P., Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006 55 1 225 233 2-s2.0-33644783770 10.2337/diabetes.55.1.225
17. Waring W. S., Moonie A., Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury. Clinical Toxicology 2011 49 8 720 728 2-s2.0-80053643935 10.3109/15563650.2011.615319
18. Sun Y., Koo S., White N., Peralta E., Esau C., Dean N. M., Perera R. J., Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Research 2004 32 22, article e188 2-s2.0-16344383409
19. Wang G., Kwan B. C.-H., Lai F. M.-M., Chow K.-M., Kam-Tao Li P., Szeto C.-C., Expression of microRNAs in the urinary sediment of patients with IgA nephropathy. Disease Markers 2010 28 2 79 86 2-s2.0-77954042328 10.3233/DMA-2010-0687
20. Fish J. E., Santoro M. M., Morton S. U., Yu S., Yeh R.-F., Wythe J. D., Ivey K. N., Bruneau B. G., Stainier D. Y. R., Srivastava D., miR-126 regulates angiogenic signaling and vascular integrity. Developmental Cell 2008 15 2 272 284 2-s2.0-48749130187 10.1016/j.devcel.2008.07.008
21. Wang S., Aurora A. B., Johnson B. A., Qi X., McAnally J., Hill J. A., Richardson J. A., Bassel-Duby R., Olson E. N., The endothelial-specific MicroRNA miR-126 governs vascular integrity and angiogenesis. Developmental Cell 2008 15 2 261 271 2-s2.0-48549106378 10.1016/j.devcel.2008.07.002
22. Asgeirsdottir S. A., van Solingen C., Kurniati N. F., Microrna-126 contributes to renal microvascular heterogeneity of vcam-1 protein expression in acute inflammation. American Journal of Physiology-Renal Physiology 2012 302 12 1630 1639
23. Metzinger-Le Meuth V., Andrianome S., Chillon J. M., Bengrine A., Massy Z. A., Metzinger L., microRNAs are dysregulated in the cerebral microvasculature of CKD mice. Frontiers in Bioscience (Elite edition) 2014 6 80 88
24. Zampetaki A., Kiechl S., Drozdov I., Willeit P., Mayr U., Prokopi M., Mayr A., Weger S., Oberhollenzer F., Bonora E., Shah A., Willeit J., Mayr M., Plasma microRNA profiling reveals loss of endothelial MiR-126 and other microRNAs in type 2 diabetes. Circulation Research 2010 107 6 810 817 2-s2.0-77957259803 10.1161/CIRCRESAHA.110.226357
25. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003 26 11 3160 3167 2-s2.0-0242300698 10.2337/diacare.26.11.3160
26. Huang F., Yang Q., Chen L., Tang S., Liu W., Yu X., Renal pathological change in patients with type 2 diabetes is not always diabetic nephropathy: a report of 52 cases. Clinical Nephrology 2007 67 5 293 297 2-s2.0-34248395631
27. Parving H.-H., Gall M.-A., Skott P., Jorgensen H. E., Lokkegaard H., Jorgensen F., Nielsen B., Larsen S., Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney International 1992 41 4 758 762 2-s2.0-0026583232
28. Wong T. Y. H., Choi P. C. L., Chun C. S., Ka F. T., Tang N. L. S., Chan A. W. H., Li P. K. T., Lai F. M.-M., Renal outcome in type 2 diabetic patients with or without coexisting nondiabetic nephropathies. Diabetes Care 2002 25 5 900 905 2-s2.0-0036582704 10.2337/diacare.25.5.900
29. Haubitz M., Good D. M., Woywodt A., Haller H., Rupprecht H., Theodorescu D., Dakna M., Coon J. J., Mischakh H., Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitis. Molecular and Cellular Proteomics 2009 8 10 2296 2307 2-s2.0-71049165855 10.1074/mcp.M800529- MCP200
30. Parving H.-H., Lehnert H., Brochner-Mortensen J., Gomis R., Andersen S., Arner P., The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. The New England Journal of Medicine 2001 345 12 870 878 2-s2.0-0035922444 10.1056/NEJMoa011489
31. Lewis E. J., Hunsicker L. G., Clarke W. R., Berl T., Pohl M. A., Lewis J. B., Ritz E., Atkins R. C., Rohde R., Raz I., Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. The New England Journal of Medicine 2001 345 12 851 860 2-s2.0-0035922447 10.1056/NEJMoa011303
32. Mogensen C. E., Neldam S., Tikkanen I., Oren S., Viskoper R., Watts R. W., Cooper M. E., Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study. British Medical Journal 2000 321 7274 1440 1444 2-s2.0-0034627208
33. Rossing K., Jacobsen P., Pietraszek L., Parving H.-H., Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial. Diabetes Care 2003 26 8 2268 2274 2-s2.0-0042525700 10.2337/diacare.26.8. 2268
34. American Diabetes Association, Diabetic nephropathy. Diabetes Care 2002 25 supplement 1 S85 S89 2-s2.0-23944511753
35. Mitchell P. S., Parkin R. K., Kroh E. M., Fritz B. R., Wyman S. K., Pogosova-Agadjanyan E. L., Peterson A., Noteboom J., O'Briant K. C., Allen A., Lin D. W., Urban N., Drescher C. W., Knudsen B. S., Stirewalt D. L., Gentleman R., Vessella R. L., Nelson P. S., Martin D. B., Tewari M., Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America 2008 105 30 10513 10518 2-s2.0-48749122914 10.1073/pnas.0804549105
36. Valadi H., Ekström K., Bossios A., Sjöstrand M., Lee J. J., Lötvall J. O., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology 2007 9 6 654 659 2-s2.0-34249302620 10.1038/ncb1596
37. Gilad S., Meiri E., Yogev Y., Benjamin S., Lebanony D., Yerushalmi N., Benjamin H., Kushnir M., Cholakh H., Melamed N., Bentwich Z., Hod M., Goren Y., Chajut A., Serum microRNAs are promising novel biomarkers. PLoS ONE 2008 3 9 2-s2.0-52349083651 10.1371/journal.pone.0003148 e3148
38. Wang G., Chan E. S., Kwan B. C., Expression of microRNAs in the urine of patients with bladder cancer. Clinical Genitourinary Cancer 2012 10 2 106 113
39. Argyropoulos C., Wang K., McClarty S., Urinary MicroRNA proiling in the nephropathy of type 1 diabetes. PLoS ONE 2013 8 1 e54662 10.1371/journal.pone. 0054662